ArticleAPL bioengineering2022

Glutathione-sensitive nanoparticles enhance the combined therapeutic effect of checkpoint kinase 1 inhibitor and cisplatin in prostate cancer.

Shirong Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.